contact@apexaiinstitute.orgLegal
EN
AAIContact us

Research & Outputs

What we've shipped, and what's next

Open work items produced across the institute's programs. Live platforms lead; shipped open resources, the research stack we build on, and items in preparation follow.

Shipped outputs

4

Syllabi & outlines

2

Open resources

Courses, keynotes, and tools under open license

Research stack

The tools and databases we build on

A layered stack — frontier language models at the top, the open-source ecosystem beneath, and curated oncology and biomedical databases anchoring every claim.

LLM Agent

Claude Code

Anthropic's agentic coding CLI — the spine of our AI-augmented research and education workflows. We use it, teach it, and build on it.

LLM Agent

Gemini 3.1 Pro

Google DeepMind's long-context multimodal model — used for medical-image review, large-document synthesis, and cross-checking against Claude outputs.

LLM Agent

GPT 5.4

OpenAI's frontier model — used as a second opinion across reasoning tasks and for multi-model voting when a single answer is not enough.

Platform

GitHub open-source tools

The open-source ecosystem — Python / TypeScript libraries, statistical toolkits, medical-imaging SDKs — assembled into reproducible pipelines.

Database

PubMed

NLM's biomedical literature database — the canonical source for systematic reviews, meta-analyses, and evidence mapping across oncology and urology.

Database

Oncology society databases

ASCO, ESMO, AACR, SITC conference abstracts and clinical-practice guidelines — the working knowledge base for first-in-human trial context and biomarker strategy.

Syllabi & outlines

Public roadmaps — outline first, full content next

Course and manuscript outlines published before the full material, so collaborators and reviewers can shape the direction early.

  • Syllabus outline

    FIH Trial-Design Methods Outline

    A public roadmap for the methodological manuscript on AI-assisted Phase I/II oncology trial design. We publish the outline before the paper so collaborators and reviewers can engage with the methodology early.

    • Problem framing — where current Phase I/II trial design decisions lose efficiency
    • AI-assisted investigator and site selection methodology
    • Starting-dose cohort allocation under sparse prior information
    • Biomarker strata identification and validation approach
    • Open-benchmark protocol — data, code, and negative-result release policy
    From Pillar 1 · Using
  • Syllabus outline

    Clinician × AI Co-taught Curriculum Outline

    Draft syllabus of the co-taught module series developed with our higher-education partner — concept scoping, weekly topics, assessment approach, and reuse notes for other accredited institutions.

    • Module 1 — Foundations: how clinicians already use AI (often without naming it)
    • Module 2 — Critical appraisal of medical-AI literature and marketing claims
    • Module 3 — Hands-on AI tooling in clinical workflow scenarios
    • Module 4 — Ethics, bias, and patient-facing communication
    • Assessment — case portfolios; reuse notes for partner institutions
    From Pillar 2 · Using

In preparation

Active work items

To be released once board-approved.

  • Research preprint

    Medical-school feasibility study (in preparation)

    Regulatory-landscape analysis (LCME, NYSED, NECHE) informing a partner institution's medical-school planning. Targeted for release after board-approved redaction.

    From Pillar 2 · Using